uniQure NV

QUREStocksBiotechnologyNetherlandsNasdaqUSD

Price

$38.19

Today

-0.2%

YTD

+60.0%

About

Founded in 1998, uniQure is a gene therapy company that develops treatments for patients with severe genetic diseases. The company has headquarters in Amsterdam and operates within the Netherlands. It is listed on the NASDAQ GS stock market under the ticker QURE.Make the QURE stock an addition to your eToro watchlist for the latest news and information.

Price chart

Closing price history for QURE (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-12.14

P/S (TTM)147.83

P/B (TTM)17.99

Market cap$2.90B

Cap tierMid-cap

Industry avg P/E-6.38

Profitability

Gross margin17.67%

EBIT margin-1082.08%

Net margin-1502.95%

ROE-228.24%

ROA-30.18%

Earnings & Revenue

Revenue (TTM)$18.09M

Revenue growth (1Y)-10.4%

EPS (TTM)-$3.51

Free cash flow$-178.15M

Total debt$545.66M

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)1.34

Employees221

Next earnings9 Nov '26

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.